A carregar...

Pooled analysis of the prospective trials of gefitinib monotherapy for EGFR-mutant non-small cell lung cancers

PURPOSE: Epidermal growth factor receptor (EGFR) mutations have been found in the majority of gefitinib-responsive non-small cell lung cancer (NSCLC) patients from retrospective studies. We sought to compile the available phase II and prospective trials of this EGFR tyrosine kinase inhibitor (TKI) t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Costa, Daniel B., Kobayashi, Susumu, Tenen, Daniel G., Huberman, Mark S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2007
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2551312/
https://ncbi.nlm.nih.gov/pubmed/17610986
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lungcan.2007.05.017
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!